Deltex Medical (UK) Performance
| DEMG Stock | 0.08 0.01 6.67% |
The firm shows a Beta (market volatility) of 0.47, which means possible diversification benefits within a given portfolio. As returns on the market increase, Deltex Medical's returns are expected to increase less than the market. However, during the bear market, the loss of holding Deltex Medical is expected to be smaller as well. At this point, Deltex Medical Group has a negative expected return of -0.81%. Please make sure to confirm Deltex Medical's information ratio, total risk alpha, maximum drawdown, as well as the relationship between the jensen alpha and treynor ratio , to decide if Deltex Medical Group performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Deltex Medical Group has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in December 2024. The newest uproar may also be a sign of mid-term up-swing for the firm private investors. ...more
Last Split Factor 839:837 | Last Split Date 2016-02-08 |
| Begin Period Cash Flow | 471 K | |
| Free Cash Flow | -1.6 M |
Deltex |
Deltex Medical Relative Risk vs. Return Landscape
If you would invest 14.00 in Deltex Medical Group on August 26, 2024 and sell it today you would lose (6.00) from holding Deltex Medical Group or give up 42.86% of portfolio value over 90 days. Deltex Medical Group is generating negative expected returns and assumes 2.9692% volatility on return distribution over the 90 days horizon. Simply put, 26% of stocks are less volatile than Deltex, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Deltex Medical Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Deltex Medical's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Deltex Medical Group, and traders can use it to determine the average amount a Deltex Medical's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.2732
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | DEMG |
Estimated Market Risk
| 2.97 actual daily | 26 74% of assets are more volatile |
Expected Return
| -0.81 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.27 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Deltex Medical is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Deltex Medical by adding Deltex Medical to a well-diversified portfolio.
Deltex Medical Fundamentals Growth
Deltex Stock prices reflect investors' perceptions of the future prospects and financial health of Deltex Medical, and Deltex Medical fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Deltex Stock performance.
| Return On Equity | -0.57 | ||||
| Return On Asset | -0.0777 | ||||
| Profit Margin | (0.72) % | ||||
| Operating Margin | (0.42) % | ||||
| Current Valuation | 3.17 M | ||||
| Shares Outstanding | 1.9 B | ||||
| Price To Book | 0.54 X | ||||
| Price To Sales | 0.85 X | ||||
| Revenue | 1.78 M | ||||
| Gross Profit | 1.84 M | ||||
| EBITDA | (1 M) | ||||
| Net Income | (1.26 M) | ||||
| Total Debt | 1.92 M | ||||
| Book Value Per Share | 0 X | ||||
| Cash Flow From Operations | (1.2 M) | ||||
| Total Asset | 5.93 M | ||||
| Retained Earnings | (57.77 M) | ||||
About Deltex Medical Performance
Assessing Deltex Medical's fundamental ratios provides investors with valuable insights into Deltex Medical's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Deltex Medical is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
Deltex Medical is entity of United Kingdom. It is traded as Stock on LSE exchange.Things to note about Deltex Medical Group performance evaluation
Checking the ongoing alerts about Deltex Medical for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Deltex Medical Group help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Deltex Medical Group generated a negative expected return over the last 90 days | |
| Deltex Medical Group has some characteristics of a very speculative penny stock | |
| Deltex Medical Group has a very high chance of going through financial distress in the upcoming years | |
| The company reported the revenue of 1.78 M. Net Loss for the year was (1.26 M) with profit before overhead, payroll, taxes, and interest of 1.84 M. | |
| Deltex Medical generates negative cash flow from operations | |
| About 68.0% of the company shares are held by company insiders |
- Analyzing Deltex Medical's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Deltex Medical's stock is overvalued or undervalued compared to its peers.
- Examining Deltex Medical's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Deltex Medical's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Deltex Medical's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Deltex Medical's stock. These opinions can provide insight into Deltex Medical's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Deltex Stock Analysis
When running Deltex Medical's price analysis, check to measure Deltex Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Deltex Medical is operating at the current time. Most of Deltex Medical's value examination focuses on studying past and present price action to predict the probability of Deltex Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Deltex Medical's price. Additionally, you may evaluate how the addition of Deltex Medical to your portfolios can decrease your overall portfolio volatility.